RNA vaccines seem to boost the effectiveness of an immune therapy for skin and lung cancer ― in an unexpected way.
A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy lived dramatically longer than those who didn’t. Researchers from the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback